At this time, posts about Humasis are rapidly increasing on portals and securities communities. Today, foreigners have tentatively sold a net 159,000 shares of Humasis, and institutions have sold a net 132,000 shares. Humasis is known as an in vitro diagnostic device company.

As of 11:32 AM on the 16th, Humasis's stock price is 4,160 KRW, up 30.0% from the previous day, with a trading volume of 26,991,805 shares, which is 677.45% of the 5-day average trading volume.

In addition to Humasis, posts by investors are also rapidly increasing for Bigtec (065450), Hanwha Solutions Preferred (009835), and KG Mobilians (046440).

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing